Related Experiment Videos
Association between the CCK-A receptor gene and panic disorder
Kiminobu Ise1, Jotaro Akiyoshi, Yukiko Horinouchi
1Department of Neuropsychiatry, Oita Medical University, Hasama-Machi Oita 879-55, Japan.
Summary
This study investigated the cholecystokinin A receptor (CCKAR) gene in panic disorder (PD) patients. Findings suggest that a specific CCKAR gene polymorphism is not associated with PD in humans.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Cholecystokinin (CCK) is a key neurotransmitter peptide implicated in brain functions.
- CCK and its receptor (CCKAR) play a role in anxiety and panic disorders (PD).
- Previous research indicated an anxiogenic effect in rats lacking CCKAR.
Purpose of the Study:
- To investigate the association between the CCKAR gene and PD in humans.
- To compare CCKAR gene polymorphisms in PD patients and healthy controls.
Main Methods:
- Analyzed the Pst I polymorphic site in the CCKAR gene (intron 1/exon 2 boundary) in 43 PD patients and controls.
- Utilized Polymerase Chain Reaction (PCR) and Pst I digestion to identify A1 and A2 alleles.
- Compared genotypic and allelic frequencies between patient and control groups using chi-square tests.
Main Results:
- Identified two alleles (A1 and A2) based on Pst I digestion.
- Observed no significant differences in CCKAR genotypic frequencies between PD patients (20.9% A1-A1, 55.8% A1-A2, 41.7% A2-A2) and controls (20.5% A1-A1, 46.2% A1-A2, 33.3% A2-A2).
- Found no significant differences in CCKAR allelic frequencies between PD patients (48.8% A1, 51.2% A2) and controls (43.6% A1, 56.4% A2).
Conclusions:
- The Pst I polymorphism within the CCKAR gene is not significantly associated with panic disorder.
- Further research may be needed to explore other CCKAR variants or related pathways in PD pathogenesis.